Explorez tous les épisodes du podcast Making science work for health

An approach to healthcare that tailors treatments and preventative measures to individual needs, personalised health is a big topic of conversation. So big that Ofori Canacoo speaks to several members of the PHG Foundation about personalised health. What it means to them, examples of where they see it working, changes that should be considered and what they think the future of personalised health could look like.

Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare. We discuss the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.
 
If you would like to find out more about what was discussed in this episode, you can find additional information on our website, https://www.phgfoundation.org/research/personalised-health/.

If you have any questions about the topic then you can email us at intelligence@phgfoundation.org. 

A complex field, host genomics research aims to identify genetic variants that might explain different individual responses to an infectious disease. 

A companion piece to our report, Host genomics: lessons for infectious disease, policy analyst and lead author of the report, Heather Turner, discusses the findings of the report and why host genomics matters for the health.

Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare. We discuss the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.
 
If you would like to find out more about what was discussed in this episode, you can find additional information on our website, phgfoundation.org.

If you have any questions about the topic then you can email us at intelligence@phgfoundation.org. 

Tanya Brigden discusses the ethical implications and regulatory challenges that should be considered in the innovative area of genome editing. In recent years, the potential of somatic genome editing has elicited both excitement and caution among researchers, clinicians, patients, and ethicists.

Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare.
 
In each episode, host Ofori Canacoo discusses with a PHG Foundation policy analyst, the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.
 
If you would like to find out more about what was discussed in this episode, you can find additional information on our website, phgfoundation.org.

Make sure to read our briefing on advanced therapy medicinal products as mentioned in the episode.

If you have any questions about the topic then you can email us at intelligence@phgfoundation.org. 

A developing area in synthetic biology, electrogenetics is hoped to become a new avenue in precision medicine, helping with the treatment of certain chronic diseases. Chaitanya Erady talks about what electrogenetics is and the ambitions for its use.

Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare.
 
In each episode, host Ofori Canacoo discusses with a PHG Foundation policy analyst, the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.
 
If you would like to find out more about what was discussed in this episode, you can find additional information on our website, phgfoundation.org.

Make sure to read our briefings on electrogenetics and advanced therapy medicinal products too.

If you have any questions about the topic then you can email us at intelligence@phgfoundation.org. 

Type 1 diabetes is a complex disease affecting millions of people across the world. Though insulin has been discovered as a treatment for patients, research is still being done to find additional and alternative methods to treat and perhaps cure type 1 diabetes. Hayley Wilson discusses how gene therapy is being used as one potential method of treatment. 

Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare.
 
In each episode, host Ofori Canacoo discusses with a PHG Foundation policy analyst, the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.
 
If you would like to find out more about what was discussed in this episode, you can find additional information on our website, phgfoundation.org.

You can read our briefing on gene therapy and type 1 diabetes here.

If you have any questions about the topic then you can email us at intelligence@phgfoundation.org. 

Bhavya Krishnan and Dr Elizabeth Redrup Hill discuss the applications of digital twins in the healthcare system, why there is growing interest, and some questions that they would like to see be explored in order to make digital twins an effective tool for healthcare and medicine.

Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare.
 
In each episode, host Ofori Canacoo discusses with a PHG Foundation policy analyst, the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.
 
If you would like to find out more about what was discussed in this episode, you can find additional information on our website, phgfoundation.org.

Regarding digital twins, you can read our explainer about this engineering concept.

If you have any questions about the topic then you can email us at intelligence@phgfoundation.org. 

Chantal Babb de Villiers, Senior Policy Analyst at the PHG Foundation, talks us through bacteriophages, otherwise known as phages, their growing interest, their current usage and what might be needed for phage therapy to take the next steps towards public healthcare.

Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare.
 
In each episode, host Ofori Canacoo discusses with a PHG Foundation policy analyst, the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.
 
If you would like to find out more about what was discussed in this episode, you can find additional information on our website, phgfoundation.org.

Regarding phages, Chantal has written a briefing on Phage therapy to treat AMR infections as well as two blogs: Examining whether viruses can combat antimicrobial resistance and Viruses for good – the case for phages.

If you have any questions about the topic then you can email us at intelligence@phgfoundation.org. 

Heather Turner, Policy Analyst at the PHG Foundation,  explains for you long-read sequencing, its potential applications and how this new technology measures up against traditional short-read sequencing.

Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare.
 
In each episode, host Ofori Canacoo discusses with a PHG Foundation policy analyst, the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.
 
If you would like to find out more about what was discussed in this episode, you can find additional information on our website, phgfoundation.org.

Heather recently wrote two briefings on long-read sequencing. Both are freely available: Clinical long-read sequencing and Long-read sequencing: Clinical applications and implementation.

If you have any questions about the topic then you can email us at intelligence@phgfoundation.org. 

Dr Sowmiya Moorthie, Senior Policy Analyst at the PHG Foundation, explains polygenic scores, their potential  - and their limitations – in predicting risk of common diseases.

Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare.
 
 In each episode, host Ofori Canacoo discusses with a PHG Foundation policy analyst, the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.
 
 Lots  more about polygenic scores  can be found on the PHG Foundation website  phgfoundation.org, where you can also read our latest report on the topic  Evaluation of polygenic score applications which was authored by Dr Moorthie.

If you have any questions about the topic then you can email us at intelligence@phgfoundation.org. 

Dr Chantal Babb de Villiers discusses gene editing animals for organ transplants to humans, otherwise known as xenotransplantation.

Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare.

In each episode, host Ofori Canacoo discusses with a PHG Foundation policy analyst, the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.

You can read Chantal's briefing on xenotransplantation here.

If you would like to find out more about what was discussed in this episode, you can find additional information on our website, phgfoundation.org.

If you have any further questions about the topic then you can email us at intelligence@phgfoundation.org. 

Dr Hayley Carr discusses inflammatory bowel disease and current research into improving patient care using genetics-driven precision medicine.

Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare.

In each episode, host Ofori Canacoo discusses with a PHG Foundation policy analyst, the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.

You can read Hayley's briefing on precision medicine for inflammatory bowel disease here.

If you would like to find out more about what was discussed in this episode, you can find additional information on our website, phgfoundation.org.

If you have any further questions about the topic then you can email us at intelligence@phgfoundation.org. 

We are delighted to present Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare.

In each episode, host Ofori Canacoo discusses with a PHG Foundation policy analyst, the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.

In the first episode, Dr Joanna Janus explains the basics of liquid biopsy, its role as an alternative to solid tissue biopsies, and its potential as a tool for monitoring the success of treatments

If you would like to find out more about what was discussed in this episode, you can find additional information on our website, phgfoundation.org.

If you have any further questions about the topic then you can email us at intelligence@phgfoundation.org.